Coagulation changes in sickle cell disease in early childhood
- PMID: 3113156
- DOI: 10.1159/000205981
Coagulation changes in sickle cell disease in early childhood
Abstract
Measurements of the coagulation system were carried out in children with sickle cell disease (SCD) in both steady state and on the 1st day of painful crisis and were compared to age- and sex-matched healthy controls. No significant differences were found in prothrombin time, partial thromboplastin time, thrombin time, reptilase time, plasma fibrinogen, antithrombin III, factor VIII:C, ristocetin-cofactor (Ri-Cof) and platelet aggregation responses to ADP, collagen and adrenaline. Abnormal aggregation responses to ristocetin were noted in all patients with SCD when compared to controls. Daily measurements during the first 4 days of painful crisis showed significant elevation of fibrinogen and Ri-Cof and enhancement of aggregation to ADP and adrenaline by the 3rd day of crisis. It was concluded that the changes noted, rather than being primarily responsible for the onset of crisis, can only be secondary changes arising from the aetiological factors of crisis, i.e. stasis and acute-phase proteins.
Similar articles
-
Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.Blood Rev. 2016 Jul;30(4):245-56. doi: 10.1016/j.blre.2015.12.003. Epub 2015 Dec 24. Blood Rev. 2016. PMID: 26776344 Free PMC article. Review.
-
Tissue factor-positive monocytes expression in children with sickle cell disease: clinical implication and relation to inflammatory and coagulation markers.Blood Coagul Fibrinolysis. 2016 Dec;27(8):862-869. doi: 10.1097/MBC.0000000000000494. Blood Coagul Fibrinolysis. 2016. PMID: 26761587
-
Serial changes in coagulation and viscosity during sickle-cell crisis.Br J Haematol. 1979 Jan;41(1):95-103. doi: 10.1111/j.1365-2141.1979.tb03685.x. Br J Haematol. 1979. PMID: 420740
-
Abnormalities of coagulation and fibrinolysis in homozygous sickle cell disease.Hematol Cell Ther. 1996 Jul;38(3):279-84. doi: 10.1007/s00282-996-0279-2. Hematol Cell Ther. 1996. PMID: 8974793
-
Hypercoagulability in sickle cell disease: a curious paradox.Am J Med. 2003 Dec 15;115(9):721-8. doi: 10.1016/j.amjmed.2003.07.011. Am J Med. 2003. PMID: 14693325 Review.
Cited by
-
Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.Blood Rev. 2016 Jul;30(4):245-56. doi: 10.1016/j.blre.2015.12.003. Epub 2015 Dec 24. Blood Rev. 2016. PMID: 26776344 Free PMC article. Review.
-
Haemostatic measurements in childhood nephrotic syndrome.Eur J Pediatr. 1991 Mar;150(5):374-8. doi: 10.1007/BF01955944. Eur J Pediatr. 1991. PMID: 2044614
-
Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease.Blood. 2016 Feb 18;127(7):810-9. doi: 10.1182/blood-2015-09-618553. Epub 2016 Jan 12. Blood. 2016. PMID: 26758919 Free PMC article. Review.
-
Developing new pharmacotherapeutic approaches to treating sickle-cell disease.ISBT Sci Ser. 2017 Feb;12(1):239-247. doi: 10.1111/voxs.12305. Epub 2016 Nov 15. ISBT Sci Ser. 2017. PMID: 28484512 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical